Jaguar Health (JAGX) Return on Capital Employed Growth (3y) (2018 - 2026)
Jaguar Health (JAGX) Return on Capital Employed Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,792.52 Bn | 1,792.46 Bn | - | - |
| 2 | Akari Therapeutics | 999.95 Bn | 999.95 Bn | - | - |
| 3 | BeOne Medicines | 475.97 Bn | 471.17 Bn | 1.35 Bn | 4,893.00 |
| 4 | Vertex Pharmaceuticals | 124.91 Bn | 117.66 Bn | 2.59 Bn | -494.00 |
| 5 | Regeneron Pharmaceuticals | 72.31 Bn | 63.56 Bn | 3.31 Bn | -649.00 |
| 6 | Belite Bio | 62.01 Bn | 62.01 Bn | - | - |
| 7 | Argenx Se | 54.23 Bn | 49.04 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.31 Bn | 35.30 Bn | 959.66 Mn | 4,853.00 |
| 9 | Revolution Medicines | 36.16 Bn | 36.16 Bn | - | -3,782.00 |
| 10 | Jaguar Health | 497,735.41 | -9.57 Mn | 19.11 Mn | 28,583.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28,583.00 |
| Dec 31, 2025 | 51,069.00 |
| Sep 30, 2025 | -9,272.00 |
| Jun 30, 2025 | -2,369.00 |
| Mar 31, 2025 | -368.00 |
| Dec 31, 2024 | 1,470.00 |
| Sep 30, 2024 | -860.00 |
| Jun 30, 2024 | -2,613.00 |
| Mar 31, 2024 | -2,835.00 |
| Dec 31, 2023 | 64.00 |
| Sep 30, 2023 | 15,421.00 |
| Jun 30, 2023 | 13,497.00 |
| Mar 31, 2023 | 1,186.00 |
| Dec 31, 2022 | -4,050.00 |
| Sep 30, 2022 | -3,559.00 |
| Jun 30, 2022 | 6,433.00 |
| Mar 31, 2022 | 6,693.00 |
| Dec 31, 2021 | 8,237.00 |
| Sep 30, 2021 | 6,449.00 |
| Jun 30, 2021 | 5,754.00 |